Weight-loss Injections Show Positive Results Among Indian Patients
Study Overview
A recent study from Max Super Speciality Hospital, Saket, New Delhi, indicates that weight-loss injections are yielding promising results among Indian patients. Led by endocrinologist Dr. Ambrish Mithal, the research was published in the Indian Journal of Endocrinology and Metabolism and followed 150 overweight and obese adults undergoing these therapies in routine clinical practice.
The study found that more than 40% of participants lost at least 10% of their body weight, a significant milestone that healthcare professionals assert can lead to considerable health improvements.
Weight Loss Results
On average, patients demonstrated a reduction of about 8% in body weight over a span of six months, translating to an estimated loss of 6 to 10 kilograms for many individuals. Nearly three-fourths of the participants achieved a minimum weight loss of at least 5%, which is recognized as necessary for health benefits including better sugar control and a lower risk of heart disease.
Dr. Ambrish Mithal noted that the findings reflect short-term outcomes over six months, stating, “This is not the final weight loss. With longer follow-up, especially at one year, the reduction is likely to be significantly greater.”
Diverse Responses to Treatment
Despite the positive results, the study revealed variations in weight loss among different groups. Participants without diabetes exhibited a markedly better response, losing nearly double the weight in comparison to those with diabetes. The authors suggest this disparity may be linked to deeper metabolic changes and insulin resistance associated with diabetic patients.
The type of medication also played a crucial role in the weight loss outcomes. Those receiving tirzepatide, a newer dual-action injection, experienced greater and quicker weight loss compared to individuals on semaglutide. Many patients reached the 10% weight loss threshold within 9 to 10 months, although doctors emphasize that the weight loss process is gradual rather than instantaneous.
Patient Demographics and Side Effects
The study also highlighted differences among demographic groups. Younger patients and first-time users of these injections achieved faster results, while those who had previously tried similar medications experienced slower weight loss.
As with any treatment, side effects were present. Common issues included nausea, bloating, and constipation, notably during the initial phase of treatment. However, these effects were manageable and typically did not require patients to discontinue their medication.
Implications for Obesity Management
This study provides insights into the real-world application of weight-loss injections, differentiating it from controlled clinical trials where conditions are tightly regulated. In everyday settings, where patients might miss doses or have varying dietary habits, the results still indicated that these drugs are effective.
Given the rising rates of obesity and diabetes in India, the study indicates a potential paradigm shift in strategies for weight management. The emphasis is gradually moving from reliance solely on diet and exercise to incorporating medical options that can significantly impact weight loss. Experts advise that while these injections are not a one-step solution, consistent usage, combined with lifestyle changes, can lead to sustained and meaningful weight loss over time.
Follow US
https://www.facebook.com/charchaexpress
https://www.youtube.com/@charcha-express
https://www.instagram.com/charcha.express/
Contents
Study OverviewA recent study from Max Super Speciality Hospital, Saket, New Delhi, indicates that weight-loss injections are yielding promising results among Indian patients. Led by endocrinologist Dr. Ambrish Mithal, the research was published in the Indian Journal of Endocrinology and Metabolism and followed 150 overweight and obese adults undergoing these therapies in routine clinical practice.The study found that more than 40% of participants lost at least 10% of their body weight, a significant milestone that healthcare professionals assert can lead to considerable health improvements.Weight Loss ResultsOn average, patients demonstrated a reduction of about 8% in body weight over a span of six months, translating to an estimated loss of 6 to 10 kilograms for many individuals. Nearly three-fourths of the participants achieved a minimum weight loss of at least 5%, which is recognized as necessary for health benefits including better sugar control and a lower risk of heart disease.Dr. Ambrish Mithal noted that the findings reflect short-term outcomes over six months, stating, “This is not the final weight loss. With longer follow-up, especially at one year, the reduction is likely to be significantly greater.”Diverse Responses to TreatmentDespite the positive results, the study revealed variations in weight loss among different groups. Participants without diabetes exhibited a markedly better response, losing nearly double the weight in comparison to those with diabetes. The authors suggest this disparity may be linked to deeper metabolic changes and insulin resistance associated with diabetic patients.The type of medication also played a crucial role in the weight loss outcomes. Those receiving tirzepatide, a newer dual-action injection, experienced greater and quicker weight loss compared to individuals on semaglutide. Many patients reached the 10% weight loss threshold within 9 to 10 months, although doctors emphasize that the weight loss process is gradual rather than instantaneous.Patient Demographics and Side EffectsThe study also highlighted differences among demographic groups. Younger patients and first-time users of these injections achieved faster results, while those who had previously tried similar medications experienced slower weight loss.As with any treatment, side effects were present. Common issues included nausea, bloating, and constipation, notably during the initial phase of treatment. However, these effects were manageable and typically did not require patients to discontinue their medication.Implications for Obesity ManagementThis study provides insights into the real-world application of weight-loss injections, differentiating it from controlled clinical trials where conditions are tightly regulated. In everyday settings, where patients might miss doses or have varying dietary habits, the results still indicated that these drugs are effective.Given the rising rates of obesity and diabetes in India, the study indicates a potential paradigm shift in strategies for weight management. The emphasis is gradually moving from reliance solely on diet and exercise to incorporating medical options that can significantly impact weight loss. Experts advise that while these injections are not a one-step solution, consistent usage, combined with lifestyle changes, can lead to sustained and meaningful weight loss over time.
